The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Open Access
- 15 July 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (2), 432-440
- https://doi.org/10.1182/blood-2005-06-2383
Abstract
Myasthenia gravis (MG) is associated with ectopic germinal centers in the thymus. Thymectomy and glucocorticoids are the main treatments but they induce operative risks and side effects, respectively. The aim of this study was to propose new therapies more efficient for MG. We hypothesized that molecules dysregulated in MG thymus and normalized by glucocorticoids may play a key role in thymic pathogenesis. Using gene chip analysis, we identified 88 genes complying with these criteria, the most remarkable being the B-cell chemoattractant (CXCL13). Its expression was increased in thymus and sera of glucocorticoid-untreated patients and decreased in response to treatment in correlation with clinical improvement. Normal B cells were actively chemoattracted by thymic extracts from glucocorticoid-untreated patients, an effect inhibited by anti-CXCL13 antibodies. In the thymus, CXCL13 was preferentially produced by epithelial cells and overproduced by epithelial cells from MG patients. Altogether, our results suggest that a high CXCL13 production by epithelial cells could be responsible for germinal center formation in MG thymus. Furthermore, they show that this gene is a main target of corticotherapy. Thus, new therapies targeting CXCL13 could be of interest for MG and other autoimmune diseases characterized by ectopic germinal center formation.Keywords
This publication has 53 references indexed in Scilit:
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Glucocorticoids in T Cell Development and FunctionAnnual Review of Immunology, 2000
- Systemic corticosteroid therapy---side effects and their managementBritish Journal of Ophthalmology, 1998
- The Thymus and the Pathogenesis of Myasthenia GravisClinical Immunology and Immunopathology, 1996
- Myasthenia GravisThe New England Journal of Medicine, 1994
- Germinal CentersAnnual Review of Immunology, 1994
- Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.JCI Insight, 1994
- Monocyte Chemoattractant Protein-1 (MCP-1) in Inflammatory Joint Diseases and Its Involvement in the Cytokine Network of Rheumatoid SynoviumClinical Immunology and Immunopathology, 1993
- Germinal center T cells are distinct helper-inducer T cellsHuman Immunology, 1991
- Complement Ligand-Receptor Interactions that Mediate Biological ResponsesAnnual Review of Immunology, 1983